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abstract
 
Human central core disease (CCD) is caused by mutations/deletions in the gene that encodes the
 
skeletal muscle ryanodine receptor (RyR1). Previous studies have shown that CCD mutations in the NH
 
2
 
-terminal
region of RyR1 lead to the formation of leaky SR Ca
 
2
 
 
 
 release channels when expressed in myotubes derived from
RyR1-knockout (dyspedic) mice, whereas a COOH-terminal mutant (I4897T) results in channels that are not
leaky to Ca
 
2
 
 
 
 but lack depolarization-induced Ca
 
2
 
 
 
 release (termed excitation-contraction [EC] uncoupling). We
show here that store depletion resulting from NH
 
2
 
-terminal (Y523S) and COOH-terminal (Y4795C) leaky CCD
mutant release channels is eliminated after incorporation of the I4897T mutation into the channel (Y523S/
I4897T and Y4795C/I4897T). In spite of normal SR Ca
 
2
 
 
 
 content, myotubes expressing the double mutants
 
lacked voltage-gated Ca
 
2
 
 
 
 release and thus exhibited an EC uncoupling phenotype similar to that of I4897T-
expressing myotubes. We also show that dyspedic myotubes expressing each of seven recently identiﬁed CCD mu-
tations located in exon 102 of the RyR1 gene (G4890R, R4892W, I4897T, G4898E, G4898R, A4905V, R4913G) be-
have as EC-uncoupled release channels. Interestingly, voltage-gated Ca
 
2
 
 
 
 release was nearly abolished (reduced
 
 
 
90%) while caffeine-induced Ca
 
2
 
 
 
 release was only marginally reduced in R4892W-expressing myotubes, indicat-
ing that this mutation preferentially disrupts voltage-sensor activation of release. These data demonstrate that
CCD mutations in exon 102 disrupt release channel permeation to Ca
 
2
 
 
 
 during EC coupling and that this region
represents a primary molecular locus for EC uncoupling in CCD.
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INTRODUCTION
 
Excitation-contraction (EC)* coupling in skeletal mus-
cle involves a mechanical interaction between dihydro-
pyridine receptors (DHPR) in the sarcolemma and ry-
anodine receptors (RyR1) or Ca
 
2
 
 
 
 release channels lo-
cated in the terminal cisternae of the SR (Melzer et al.,
1995). DHPR-RyR1 mechanical coupling is a bidirec-
tional signaling interaction since DHPRs trigger the
opening of SR Ca
 
2
 
 
 
 release channels (orthograde cou-
pling) and the presence of RyR1 enhances the Ca
 
2
 
 
 
-
conducting activity and modiﬁes the L-channel gating
properties of the DHPR (retrograde coupling) (Nakai
et al., 1996; Avila and Dirksen, 2000; Dirksen, 2002).
The central roles of DHPR and RyR1 proteins in nor-
mal skeletal muscle Ca
 
2
 
 
 
 signaling is emphasized by the
fact that mutations in both of these proteins account
for several different human congenital muscle diseases
(e.g., hypokalemic periodic paralysis, malignant hyper-
thermia [MH], and central core disease [CCD]) (Leh-
mann-Horn and Jurkat-Rott, 1999).
 
CCD is a human autosomal dominant, nonprogres-
sive myopathy characterized by hypotonia and proximal
muscle weakness in infancy (Shuaib et al., 1987). At
least 32 different point mutations or deletions in the
gene that encodes RyR1 are known to cause CCD in hu-
mans (for review see Dirksen and Avila, 2002). All of
the CCD mutations identiﬁed to date are located within
three relatively restricted regions of the RyR1 protein: 3
mutations in MH/CCD region 1 (residues 35–614), 4
mutations in MH/CCD region 2 (residues 2129–2458),
and 15 mutations in MH/CCD region 3 (COOH-termi-
nal region, including residues 4136–4973).
 
Functional studies of MH and CCD mutant RyR1s
proteins expressed in either heterologous systems (e.g.,
HEK-293 cells) or skeletal myotubes derived from RyR1-
knockout (dyspedic) mice indicate that CCD mutations
in MH/CCD regions 1 and 2 lead to the formation of
 
SR Ca
 
2
 
 
 
 release channels that exhibit varying degrees of
Ca
 
2
 
 
 
 leak that manifests as an elevation in resting cal-
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Abbreviations used in this paper:
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contraction; L-currents, L-type Ca
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 currents; MH, malignant hyper-
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cium and a depletion of SR Ca
 
2
 
 
 
 stores (Treves et al.,
1994; Tong et al., 1997, 1999; Lynch et al., 1999; Mon-
nier et al., 2000; Avila and Dirksen, 2001). As a conse-
quence of store depletion, voltage-gated Ca
 
2
 
 
 
 release
during EC coupling is markedly reduced (Avila and
Dirksen, 2001), presumably resulting from a reduction
in both the driving force for Ca
 
2
 
 
 
 release from the SR
and the regulation of release channel activity by luminal
Ca
 
2
 
 
 
 (Sitsapesan and Williams, 1997).
In contrast to that found for CCD mutations in MH/
CCD regions 1 and 2, resting Ca
 
2
 
 
 
 levels and SR Ca
 
2
 
 
 
content are normal in dyspedic myotubes expressing a
COOH-terminal mutation in RyR1 (I4897T) (Avila et
al., 2001a). Nevertheless, I4897T-expressing dyspedic
myotubes do not release SR Ca
 
2
 
 
 
 after stimulation by
either caffeine or voltage and coexpression of wild-type
and I4897T mutant RyR1 proteins only partially re-
stores caffeine and voltage-gated Ca
 
2
 
 
 
 release. These
results suggest that the I4897T mutation leads to a
functional uncoupling of sarcolemmal depolarization
from the efﬁcient release of SR Ca
 
2
 
 
 
 (Avila et al.,
2001a). We have referred to this phenomenon by
which voltage-gated SR calcium release is reduced in a
manner independent of changes in SR Ca
 
2
 
 
 
 content in
I4897T-expressing dyspedic myotubes as “EC uncou-
pling.” However, our suggestion that muscle weakness
arising from the I4897T mutation operates via a funda-
mentally distinct mechanism (EC uncoupling) from
that of the NH
 
2
 
-terminal mutants (leaky channels) is
controversial since other studies have suggested that
I4897T mutant release channels act as leaky release
channels in transfected HEK293 cells (Lynch et al.,
1999) and lymphocytes obtained from CCD patients
possessing this mutation (Tilgen et al., 2001).
We therefore set out to more rigorously test the valid-
ity of our hypothesis that the I4897T mutation operates
via a fundamentally distinct cellular mechanism than
that caused by CCD mutations that lead to enhanced
SR Ca
 
2
 
 
 
 leak. Our results indicate that normal levels of
resting Ca
 
2
 
 
 
 and SR Ca
 
2
 
 
 
 content are restored after in-
corporation of the I4897T mutation into leaky chan-
nels. In addition, we found that all seven of the CCD
mutations identiﬁed in exon 102 of the RyR1 gene lead
to varying degrees of EC uncoupling following reconsti-
tution in dyspedic myotubes, thus conﬁrming this re-
gion of RyR1 as a primary molecular locus for EC un-
coupling in CCD.
 
MATERIALS AND METHODS
 
Preparation and cDNA Injections of Dyspedic Myotubes
 
Primary cultures of myotubes were prepared from skeletal mus-
cle of newborn dyspedic mice as described previously (Nakai et
al., 1996; Avila and Dirksen, 2000). Each of the different CCD
point mutations in RyR1 used in this study (Y523S, Y4795C,
G4890R, R4892W, I4897T, G4898E, G4898R, A4905V, and
 
R4913G) were introduced into a rabbit RyR1 cDNA using stan-
dard two-step site-directed mutagenesis strategies and the entire
PCR-modiﬁed cDNA portion of each clone was ultimately con-
ﬁrmed by sequence analysis. Expression of wild-type RyR1 and
the different CCD mutations in RyR1 was achieved by nuclear mi-
croinjection of cDNAs encoding CD8 (0.2 
 
 
 
g/
 
 
 
l) and the appro-
priate expression plasmid (0.5 
 
 
 
g/
 
 
 
l) 4–6 d after of initial plat-
ing of myoblasts (Avila et al., 2001a).
 
Measurements of Resting Ca
 
2
 
 
 
 and Caffeine-, 4-Chloro-m-
Cresol–, and CPA-induced Ca
 
2
 
 
 
 Transients in Intact Myotubes
 
Resting Ca
 
2
 
 
 
 and drug-induced changes in intracellular Ca
 
2
 
 
 
were measured in intact myotubes loaded with the ﬂuorescent
Ca
 
2
 
 
 
 indicator Indo-1 AM (Molecular Probes) as described previ-
ously (Avila et al., 2001a,b). Indo-1–loaded myotubes were
bathed in a normal rodent Ringer’s solution (containing 145
mM NaCl, 5 mM KCl, 2 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 10 mM HEPES,
pH 7.4) and excited at 350 nm. Fluorescence emission at 405 and
485 nm was collected using a photomultiplier detection system
and the results presented as the ratio (R) of F
 
405
 
/F
 
485
 
. The rest-
ing F
 
405
 
/F
 
485
 
 ratio was converted to cytosolic Ca
 
2
 
 
 
 levels using an
in situ calibration approach described previously (Avila et al.,
2001a). Relative changes in global Ca
 
2
 
 
 
 levels were subsequently
monitored after application of maximal concentrations of either
caffeine (10 mM), 4-chloro-m-cresol (4-cmc, 500 
 
 
 
M), or cyclopi-
azonic acid (CPA, 30 
 
 
 
M) using a rapid perfusion system that
permits fast, local application of agonist as well as rapid washout
with control solution (Avila et al., 2001a,b). In some experi-
ments, Indo-1 AM–loaded myotubes bathed in Ringer’s were
stimulated (8.0 V for 20 ms at 0.1 Hz for 30 s) using an extracel-
lular pipette before the application of RyR1 agonists. Peak intra-
cellular Ca
 
2
 
 
 
 changes in response to agonist application are ex-
pressed as 
 
 
 
Ratio (R
 
agonist
 
 
 
 
 
 R
 
baseline
 
).
 
Simultaneous Measurements of Macroscopic Ca
 
2
 
 
 
 Currents 
and Ca
 
2
 
 
 
 Transients
 
The whole-cell patch clamp technique was used to simulta-
neously measure L-currents and Ca
 
2
 
 
 
 transients in expressing
myotubes as described previously (Avila and Dirksen, 2000, 2001;
Avila et al., 2001a,b). Four different series of experiments were
carried-out, and the results for each experimental condition are
plotted with the corresponding control condition (RyR1). Thus,
results obtained from RyR1-expressing myotubes were collected
in four different groups: group I (
 
n
 
 
 
 
 
 18), group II, (
 
n
 
 
 
 
 
 14),
group III (
 
n
 
 
 
 
 
 8), and group IV (
 
n
 
 
 
 
 
 9). Peak L-currents (linear
components subtracted using a P/3 protocol) were normalized
to cell capacitance (pA/pF), plotted as a function of the mem-
brane potential, and ﬁtted according to: I 
 
  
 
G
 
max
 
*(V
 
m
 
 
 
  
 
V
 
rev
 
)/
(1 
 
  
 
exp[(V
 
G1/2
 
 
 
  
 
V
 
m
 
)/
 
k
 
G
 
]) where V
 
rev
 
 is the extrapolated reversal
potential of the Ca
 
2
 
 
 
 current, V
 
m
 
 is the membrane potential dur-
ing the test pulse, G
 
max
 
 is the maximum L-channel conductance,
V
 
G1/2
 
 is the voltage for half activation of G
 
max
 
, and 
 
k
 
G
 
 is a slope
factor. Relative changes in cytosolic Ca
 
2
 
 
 
 in patch clamp experi-
ments were recorded in Fluo-3 dialyzed myotubes. Fluorescence
traces were analogue ﬁltered (
 
 
 
 
 
 
 
 0.5 ms, RC ﬁlter) before digiti-
zation at 10 kHz and expressed as 
 
 
 
F/F ([F
 
peak
 
 
 
  
 
F
 
Base
 
]/F
 
Base
 
).
The magnitude of maximal voltage-gated calcium release ((
 
 
 
F/
F)
 
max
 
) was plotted as a function of the membrane potential, and
ﬁtted according to: 
 
 
 
F/F 
 
 
 
 (
 
 
 
F/F
 
max
 
) /{1 
 
  
 
exp [(V
 
F1/2
 
 
 
  
 
V
 
m
 
)/
 
k
 
F
 
]}, where 
 
 
 
F/F
 
max
 
 is the calculated maximal ﬂuorescence
change during the test pulse, V
 
F1/2
 
 is the midpoint potential, and
kF is a slope factor. The internal solution contained (in mM): 145
Cs-Aspartate, 10 CsCl, 0.1 Cs2-EGTA, 1.2 MgCl2, 5 Mg-ATP, 0.2 K5-
Fluo-3, 10 HEPES, pH 7.4. The external solution contained (in
mM): 145 TEA-Cl, 10 CaCl2, 0.003 TTX, and 10 HEPES, pH 7.4.T
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All experiments were performed at room temperature (20–
24 C) and data are presented as mean   SEM. When indicated,
signiﬁcant differences (unpaired t tests) were determined using
the software package Sigma Plot 2000 (SPSS). Statistic analysis
was carried out by comparing every experimental condition ver-
sus its corresponding control group (RyR1) collected concur-
rently. Unless speciﬁed, differences were determined to be signif-
icant at P   0.05.
RESULTS
The I4897T Mutation Blocks SR Ca2  Leak through Y523S 
and Y4795C CCD Mutant Ca2  Release Channels
We hypothesized that if the I4897T mutation results in
SR Ca2  release channels that poorly permeate Ca2 ,
then incorporation of this mutation into a leaky chan-
nel should restore normal levels of resting Ca2  and SR
Ca2  content. To test this idea, we evaluated the effects
of incorporating the I4897T mutation into a severely
leaky NH2-terminal CCD mutant release channel (Fig.
1, Y523S). For these experiments, myoplasmic Ca2  lev-
els were monitored in Indo-1 AM–loaded RyR1- and
Y523S-expressing dyspedic myotubes before and after
application of a maximal concentration of CPA, an
agent that increases cytosolic Ca2  by reversibly inhibit-
ing SR Ca2 -ATPase pumps. Compared with RyR1-
expressing dyspedic myotubes, Y523S-expressing myo-
tubes exhibit a substantially elevated resting Ca2  level
(Fig. 1 B) and a reduction in CPA-releasable SR Ca2 
stores (Fig. 1 C). Interestingly, increased SR Ca2  leak
can also result from a CCD mutations in the COOH-ter-
minal region of RyR1 (MH and CCD region 3) since
dyspedic myotubes expressing the Y4795C CCD muta-
tion also exhibit elevated resting Ca2  levels and a re-
duction in SR Ca2  content (Fig. 1, Y4795C). Consis-
tent with the hypothesis that the I4897T mutation
disrupts Ca2  permeation through SR Ca2  release
channels, expression of double mutant RyR1 proteins
that incorporate both the I4897T and either Y523S
(Y523S/I4897T) or Y4795C (Y4795C/I4897T) resulted
in total restoration of normal levels of both resting
Ca2  and SR Ca2  content (Fig. 1, B and C).
Voltage-gated SR Ca2  Release Is Abolished in Y523S/I4897T- 
and Y4795C/I4897T-expressing Dyspedic Myotubes
Fig. 1 demonstrates that the I4897T mutation blocked
Ca2  leak through both Y523S and Y4795C CCD mu-
tant release channels, consistent with a mutation that
Figure 1. The I4897T CCD mutation
blocks SR Ca2  leak through Y523S and
Y4795C release channels. (A) Representa-
tive CPA-induced Ca2  responses (30  M
CPA, gray bars) in Indo-1 AM–loaded dys-
pedic myotubes expressing wild-type RyR1,
Y523S, Y4795C, I4897T, Y523S/I4897T,
Y4795C/I4897T. A dotted line represent-
ing the average resting ﬂuorescence of
RyR1-expressing myotubes is shown for
comparison. (B) Average resting Ca2  lev-
els of dyspedic myotubes expressing wild-
type RyR1, Y523S, Y4795C, I4897T, Y523S/
I4897T, and Y4795C/I4897T. (C) Average
steady-state CPA-induced Ca2  responses
(  Ratio   R CPA    R baseline) for dyspedic
myotubes expressing wild-type RyR1,
Y523S, Y4795C, I4897T, Y523S/I4897T,
Y4795C/I4897T. Asterisks indicate signiﬁ-
cant differences (P   0.05) compared with
RyR1.T
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disrupts Ca2  permeation of the release channel. We
next used the whole-cell patch clamp technique in con-
junction with a Ca2 -sensitive dye to evaluate the im-
pact of combining the I4897T mutation with NH2-ter-
minal and COOH-terminal leaky SR Ca2  channels on
bidirectional coupling between DHPR and RyR1 pro-
teins (Fig. 2). L-type Ca2  currents (L-currents) and rel-
ative changes in intracellular Ca2  were simultaneously
monitored during brief (30 ms) depolarizations to po-
tentials between  50 and 70 mV. Similar to that ob-
served for wild-type RyR1 and NH2-terminal leaky CCD
mutant release channels (Avila and Dirksen, 2001), ex-
pression of the Y4795C CCD mutant in dyspedic myo-
tubes fully restored the Ca2  conducting activity of the
DHPR (Fig. 2 B). However, maximal voltage-gated SR
Ca2  release was signiﬁcantly reduced (maximal  F/F
was 38% smaller in Y4795C-expressing myotubes) and
shifted   15 mV to more hyperpolarizing potentials
compared with that of RyR1 (Fig. 2, C and D). The
large hyperpolarizing shift in the voltage dependence
of SR Ca2  release is most clearly seen at threshold po-
tentials (e.g.,  10 mV in Fig. 2 A). Thus, the effects of
the Y4795C mutation were less severe than that of the
Y523S mutation but quantitatively similar to that of
the R164C CCD mutation (Avila and Dirksen, 2001).
Importantly, dyspedic myotubes expressing double
mutants of I4897T and either Y523S (Y523S/I4897T)
or Y4795C (Y4795C/I4897T) exhibited normal L-type
Ca2  channel activity (Fig. 2 B), but lacked voltage-
gated SR Ca2  release similar to that of I4897T-express-
ing myotubes (Fig. 2, A and C). The extremely small
Ca2  transients observed in myotubes expressing the
double mutants most likely arise from Ca2  inﬂux
through the DHPR since they were barely detectable
(maximal  F/F  0.1) and exhibited a bell-shaped volt-
age dependence identical to that of L-channel activa-
tion (Fig. 2, C and D), a result identical to that ob-
served for I4897T-expressing myotubes (Avila et al.,
2001a). Thus, the double mutants exhibit an EC un-
coupling behavior identical to that of homozygous
Figure 2. The I4897T mutation converts NH2-
terminal (Y523S) and COOH-terminal (Y4795C)
leaky SR Ca2  release channels into EC uncou-
pled release channels. (A) Representative voltage-
gated Ca2  transients ( F/F) elicited by 30-ms
test pulses to the indicated potentials in RyR1-,
Y4795C-, Y4795C/I4897T-, and Y523S/I4897T-
expressing dyspedic myotubes. Similar to that ob-
served for Y523S-expressing myotubes (Avila and
Dirksen, 2001), voltage-gated Ca2  release acti-
vates at more negative potentials (i.e.,  10 mV)
in Y4795C-expressing dyspedic myotubes. (B) Av-
erage peak Ca2  current activation curves for
Y4795C- (left, open circles), Y4795C/I4897T-
(middle, open circles), and Y523S/I4897T- (right,
open circles) expressing dyspedic myotubes com-
pared with that attributable to wild-type RyR1
(closed circles). (C) Average voltage dependence
of peak intracellular Ca2  transients ( F/F   V)
for Y4795C- (left, open circles), Y4795C/I4897T-
(middle, open circles), and Y523S/I4897T- (right,
open circles) expressing dyspedic myotubes com-
pared with that attributable to wild-type RyR1
(closed circles). The broken lines represent
curves obtained from ﬁtting data obtained for
Y4785C- (middle) and Y523S- (right) expressing
myotubes. (D) The  F/F   V data and curves in
C are replotted following normalization to their
respective maximal values. All data were acquired
from three different sets of experiments and rep-
resent the average values from a total of 9 Y4795C-,
9 Y4795C/I4897T-, 8 Y523S/I4897T-, and 40
RyR1-expressing myotubes. The controls for each
different set of experiments were plotted together
with the corresponding experimental condition
that was investigated simultaneously. The number
of RyR1 controls collected for Y4795C-, Y4795C/
I4897T-, and Y523S/I4897T-expressing myotubes
were 18, 14, and 8, respectively.T
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I4897T-expressing myotubes, demonstrating that the
EC-uncoupling phenotype caused by the I4897T muta-
tion dominates in myotubes expressing the double mu-
tants.
CCD Mutations in Exon 102 of the RyR1 Gene Result in
EC Uncoupling
Of the different CCD mutations in RyR1 that have been
reconstituted in dyspedic myotubes, six are known to
promote varying degrees SR Ca2  leak (R164C, I404M,
Y523S, R2163H, R2435H, Y4795C), whereas only one
(I4897T) has been shown to function as an EC uncou-
pled channel (Avila and Dirksen, 2001; Avila et al.,
2001a). However, if EC uncoupling represents an im-
portant cellular mechanism for muscle weakness in
CCD, then other CCD mutations in RyR1 might also be
expected to result in EC uncoupling. A logical place to
start would be an analysis of the six newly identiﬁed
CCD mutations (G4891R, R4893W, G4899R, G4899E,
A4906V, and R4914G) located in exon 102 of human
RyR1 gene (Fig. 3 A), since this exon encodes the ma-
jority of the linker between RyR1 transmembrane re-
gions 3 and 4 (in the model of Takeshima et al. [1989])
and the entire putative pore-lining/selectivity ﬁlter of
the channel (Gao et al., 2000). Accordingly, we investi-
Figure 3. The exon 102 CCD mutations in RyR1 exhibit normal resting Ca2  levels and CPA-sensitive Ca2  release, but a signiﬁcant re-
duction in caffeine-induced Ca2  release. (A) Amino acid sequence encoded by exon 102 of the human RyR1 gene. Seven different CCD
mutations (G4891R, R4893W, I4898T, G4899E, G4899R, A4906V, and R4914G) have been identiﬁed for six different exon 102 amino acids
(boxed letters), four of which are located within the putative pore-lining region of RyR1 (black bar). (B) Representative maximal caffeine-
(10 mM, top) and CPA- (30  M, bottom) induced Ca2  responses in Indo-1 AM–loaded dyspedic myotubes expressing wild-type RyR1,
R4892W, G4898R, and A4905V (numbers correspond to rabbit RyR1 sequence). The dotted line represents the average resting ratio of
RyR1-expressing myotubes. (C–E) Average resting Ca2  level (C), steady-state CPA response (D), and peak caffeine response (E) for dys-
pedic myotubes expressing wild-type RyR1 and each of the seven different exon 102 CCD mutations in RyR1. *, P   0.01 compared with
RyR1;  , P   0.05 compared with RyR1.T
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gated effects on resting Ca2  and changes in intracellu-
lar Ca2  after exposure to caffeine (10 mM) and CPA
(30  M) in dyspedic myotubes expressing each of the
seven different exon 102 CCD mutations in RyR1 (Fig.
3 B). Resting Ca2  levels (Fig. 3 C) and CPA responses
(Fig. 3 D) were not signiﬁcantly different between dys-
pedic myotubes expressing wild-type RyR1 and any of
the exon 102 CCD mutations in RyR1, indicating that
these mutations do not cause signiﬁcant SR Ca2  deple-
tion. In spite of the presence of normal SR Ca2  con-
tent, caffeine-induced SR Ca2  release was reduced for
each of the exon 102 CCD mutations in RyR1 (Fig. 3
E). Interestingly, caffeine-induced Ca2  release was
only partially reduced for two of the exon 102 mutant
release channels (see R4892W and A4905V in Fig. 3 E),
indicating that SR Ca2  release may only be partially re-
duced by these particular mutations. This effect was not
due to a decrease in caffeine sensitivity since release
was not greater for these constructs following the appli-
cation of 30 mM caffeine (unpublished data).
We next characterized the effects of expression in
dyspedic myotubes of the exon 102 CCD mutations
on RyR1-mediated restoration of both voltage-gated
SR Ca2  release (orthograde coupling, deﬁned as
Ca2  transients that exhibit a sigmoidal voltage-depen-
dence) and L-type Ca2  channel activity (retrograde
coupling). Fig. 4 A shows representative Ca transients
recorded from myotubes expressing wild-type RyR1
Figure 4. Voltage-gated Ca2  release is reduced by exon 102 CCD mutations in RyR1. (A) Representative voltage-gated Ca2  transients
( F/F) elicited by 30-ms test pulses to the indicated potentials in RyR1-, R4892W-, G4898R-, and A4905V-expressing dyspedic myotubes.
(B) Average peak Ca2  current activation curves for G4890R-, R4892W, G4898E, G4898R, A4905V-, and R4913G-expressing myotubes
(open circles) compared with that attributable to wild-type RyR1 (closed circles). (C) Average voltage dependence of peak intracellular
Ca2  transients for G4890R-, R4892W-, G4898E-, G4898R-, A4905V-, and R4913G-expressing myotubes (open circles) compared with that
attributable to wild-type RyR1 (closed circles). (D) The  F/F   V data and curves in C normalized to their respective maximal values. Dys-
pedic myotubes expressing either the G4898E (n   8), R4892W (n   8), or the R4913G (n   9) CCD mutants were compared with eight
separate RyR1-expressing myotubes. Dyspedic myotubes expressing the G4890R (n   8), A4905V (n   10), or the G4898R (n   8) CCD
mutants were collected together with nine separate RyR1-expressing myotubes.T
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and three different exon 102 CCD mutants. Average
peak L-current density (Fig. 4 B), Ca2 -transient magni-
tude (Fig. 4 C), and the normalized voltage depen-
dence of these Ca2  transients (Fig. 4 D) for each exon
102 mutant is plotted (open circles) together with its
matching control (RyR1, closed circles). Similar to that
observed for I4897T (Avila et al., 2001a), homozygous
expression of each of the other exon 102 CCD mutants
fully restored L-type Ca2  channel activity to a degree
identical to that of wild-type RyR1 (Fig. 4 B). The com-
plete restoration of retrograde coupling ¬indicates that
the exon 102 CCD mutants were synthesized, properly
targeted to sarcolemmal-SR junctions, and functionally
interacted with DHPRs present within these junctions.
In contrast to the complete restoration of retrograde
coupling, voltage-gated SR Ca2  release was absent in
G4890R-, G4898E-, G4898R-, and R4913G-expressing
dyspedic myotubes. Interestingly, maximal voltage-gated
Ca2  release was only partially reduced in dyspedic myo-
tubes expressing R4892W (85%) and A4905V (36%),
the same two constructs that also resulted in a partial
reduction in caffeine-induced Ca2  release (see Fig. 3).
In spite of this reduction, voltage-gated Ca2  release of
R4892W- and A4905V-expressing myotubes exhibited a
sigmoidal voltage dependence (Fig. 4, C and D, and
representative traces in Fig. 4 A) that was not shifted
signiﬁcantly from that of wild-type RyR1 (VF1/2 was
8.6    1.1, 11.3   1.8, and 8.9   1.9 for RyR1-,
R4892W-, and A4905V-expressing myotubes, respec-
tively, P   0.05).
The R4892W Mutation Preferentially Disrupts Voltage Sensor 
Activation of the SR Ca2  Release Channel
Results obtained in Figs. 3 and 4 indicate that both
caffeine and voltage-gated SR Ca2  release are re-
duced to a similar degree for most of the exon 102
CCD mutations in RyR1. However, the R4892W muta-
tion appeared somewhat unique in this regard since
R4892W-expressing myotubes exhibited a large reduc-
tion in maximal voltage-gated SR Ca2  release ( 85%),
whereas caffeine-induced Ca2  release was only margin-
ally reduced. To more rigorously test whether voltage-
gated Ca2  release is preferentially disrupted by the
R4892W mutation in RyR1, we monitored electrically
evoked and caffeine-induced Ca2  release from individ-
ual Indo-1 AM–loaded myotubes expressing either
RyR1, R4892W, or I4897T. For these experiments, volt-
age-gated Ca2  release was ﬁrst activated by a brief train
of supramaximal electrical stimuli (8 V for 20 ms at 0.1
Hz for 30 s) using an extracellular electrode placed ad-
Figure 5. The R4892W mu-
tation preferentially disrupts
voltage-gated Ca2  release.
(A) Representative traces of
electrical-, caffeine-, and 4-cmc–
induced Ca2  transients re-
corded from Indo-1 AM–
loaded RyR1- (left), R4892W-
(middle), and I4897T- (right)
expressing myotubes. A brief
train of supramaximal electri-
cal stimuli (8 V for 20 ms at
0.1 Hz for 30 s) (arrows) was
delivered before sequential
applications of 10 mM caf-
feine (ﬁrst bar), control
Ringer’s, 500  M 4-cmc (sec-
ond bar), and a ﬁnal wash
with control Ringer’s. (B)
Average electrically acti-
vated  (black bars), caffeine-
induced (gray bars), and
4-cmc–induced (white bars)
Ca2  transients for RyR1-,
R4892W-, and I4897T-express-
ing myotubes. (C) The aver-
age magnitude of maximal
voltage-gated Ca2  release
(obtained from experiments
like those depicted in Fig. 4C) are plotted as a function of the average maximal caffeine response for RyR1 and each of the exon 102 CCD
mutant RyR1 proteins. Symbols represent RyR1 (closed circle), G4890R (open diamond), R4892W (gray circle), G4898E (open triangle),
G4898R (inverted open triangle), A4905V (open circle), and R4913G (open square). The symbols for the G4898R and R4913G mutants
are plotted behind the symbol for G4890R.T
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jacent to the cell of interest (Fig. 5 A, arrows). Shortly
thereafter, myotubes were sequentially exposed to 60-s
applications of caffeine (10 mM), control Ringer’s,
4-cmc (500  M), and a ﬁnal wash with control Ringer’s
(Fig. 5 A). In RyR1-expressing myotubes, electrical
stimulation evoked rapid voltage-gated Ca2  transients
that were typically somewhat smaller than maximal
Ca2  release activated by 10 mM caffeine (Fig. 5 A,
left). Similar to uninjected dyspedic myotubes, I4897T-
expressing myotubes completely lacked Ca2  transients
in response to either electrical stimulation or exposure
to the RyR1-selective agonist 4-cmc and responded only
weakly or not at all to 10 mM caffeine (Fig. 5 A, right).
The small caffeine response in uninjected and I4897T-
expressing dyspedic myotubes (see also Fig. 3 E) pre-
sumably arises from a low endogenous expression of
the type 3 ryanodine receptor in dyspedic myotubes
(Takeshima et al., 1995). On the other hand, although
R4892W-expressing myotubes exhibited very small or
undetectable electrically evoked Ca2  transients, 10
mM caffeine (but not 4-cmc) was still able to induce a
signiﬁcant release of SR Ca2  (Fig. 5 A, middle). Aver-
age responses of RyR1-, I4897T-, and R4892W-express-
ing myotubes to electrical stimulation, caffeine, and
4-cmc are summarized in Fig. 5 B. There was a strong
correlation (r   0.98) between the magnitude of maxi-
mal caffeine-induced and voltage-gated SR Ca2  release
(as determined in Fig. 4) for all of the exon 102 CCD
mutations in RyR1 except R4892W (Fig. 5 C). Even the
partial reduction in voltage- and caffeine-induced Ca2 
release observed in A4905V-expressing myotubes was
adequately described by this correlation. Although we
have not directly determined if R4892W-expressing
myotubes are indeed capable of ﬁring action potentials
in response to an extracellular stimulus, the data pre-
sented in Figs. 3–5 provide compelling evidence that
the R4892W mutation disrupts voltage sensor activation
of release to a greater extent than that triggered by caf-
feine, making it unique among the identiﬁed CCD mu-
tations in exon 102 of RyR1.
DISCUSSION
Leaky Channels Can Result from CCD Mutations in the 
COOH-terminal Region of RyR1
Based on results obtained after reconstitution of CCD
mutant RyR1 proteins in dyspedic myotubes, we have
proposed two fundamentally distinct cellular mecha-
nisms for muscle weakness in CCD (leaky and EC un-
coupled SR Ca2  release channels) (Avila and Dirksen,
2001; Avila et al., 2001a; Dirksen and Avila, 2002). Our
previous work has shown that expression of NH2-termi-
nal CCD mutants in dyspedic myotubes resulted in
varying degrees of SR Ca2  leak (reduced voltage-gated
release resulting from SR Ca2  depletion), while a
COOH-terminal mutant (I4897T) results in EC uncou-
pling (reduced voltage-gated release in the absence of
detectable store depletion). These observations raised
the possibility that NH2-terminal CCD mutations (MH/
CCD regions 1 and 2) result in leaky release channels
while COOH-terminal CCD mutations result in EC un-
coupling (MH/CCD region 3). However, such a clear
structural division between mechanisms does not ap-
pear to be accurate since we now show that a COOH-
terminal CCD mutation (Y4795C) also exhibits all the
hallmarks of an NH2-terminal leaky SR Ca2  release
channel (elevated resting Ca2 , reduced SR Ca2  con-
tent, hyperpolarized-shifted VF1/2, reduced maximal
 F/F).
CCD Mutations in the Pore Region of RyR1 Markedly Reduce 
SR Ca2  Release
Our proposal that the I4897T mutation operates via a
mechanism distinct from that of leaky CCD mutant re-
lease channels is controversial since I4897T mutant re-
lease channels promote Ca2  leak from intracellular
Ca2  stores after expression in HEK293 cells (Lynch et
al., 1999). In addition, increased SR Ca2  leak was also
observed in human lymphocytes obtained from CCD
patients heterozygous for the I4897T mutation (Tilgen
et al., 2001). To more rigorously test our hypothesis
that the I4897T mutation leads to SR Ca2  release
channels that poorly permeate Ca2  in a skeletal mus-
cle environment, we determined whether the I4897T
mutation could block SR Ca2  depletion caused by
leaky CCD mutant release channels. Accordingly, we
found that incorporation of the I4897T mutation into
leaky release channels arising from either NH2-termi-
nal (Y523S) or COOH-terminal (Y4795C) CCD muta-
tions in RyR1 blocked the ability of these mutations to
cause store depletion and an elevation in resting Ca2 .
In addition, although the I4897T mutation prevented
SR Ca2  leak through leaky CCD mutant release chan-
nels, myotubes expressing the double mutants were EC
uncoupled since they completely lacked voltage-gated
SR Ca2  release (i.e., Ca2  transients that exhibit a sig-
moidal voltage dependence). These results support the
idea that the I4897T mutation greatly inhibits Ca2  per-
meation through the SR Ca2  release channel.
As a second test, we surmised that if EC uncoupling
represents an important cellular mechanism for muscle
weakness in CCD, then other CCD mutations in RyR1
would also be likely to operate via this mechanism.
Exon 102 of the gene encoding the human RyR1 pro-
tein encodes 52 amino acids, including the entire puta-
tive RyR pore-lining/selectivity ﬁlter of the channel.
Exon 102 apparently represents a highly susceptible re-
gion for CCD since seven different disease causing mu-
tations within six different amino acid residues have
been identiﬁed to date. We hypothesized that muta-T
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tions to key pore-lining residues of the channel en-
coded by exon 102 that contribute signiﬁcantly to Ca2 
permeation of the open channel would result in EC-
uncoupled release channels. Our results indicate that
all of the exon 102 CCD mutations in RyR1 result in a
marked reduction in voltage-gated SR Ca2  release that
occurs in the absence of a measurable change in rest-
ing Ca2  or SR Ca2  content, conﬁrming that this re-
gion of RyR1 represents a primary molecular locus for
EC uncoupling in CCD.
Homozygous expression in dyspedic myotubes of
ﬁve of the seven identiﬁed exon 102 CCD mutations
in RyR1 (G4890R, I4897T, G4898E, G4898R, and
R4913G) results in a complete loss of voltage-gated SR
Ca2  release that occurs in the absence of a signiﬁcant
change in either resting Ca2 , SR Ca2  content, or ret-
rograde coupling with sarcolemmal DHPRs (complete
EC uncoupling). However, the other two exon 102 mu-
tations were unique in that voltage-gated SR Ca2  re-
lease was only partially reduced ( 85% for R4892W
and   36% for A4905V; partial EC uncoupling). Al-
though reduced in magnitude, the residual voltage-
gated Ca2  release attributable to these mutants ex-
hibited a voltage dependence (VF1/2) that was not
signiﬁcantly different from that of wild-type RyR1. The
normal voltage dependence of Ca2  release in R4892W-
and A4905V-expressing myotubes is similar to what we
have shown previously for the partial restoration of re-
lease observed after coexpression of wild-type RyR1
and I4897T (Avila et al., 2001a). Thus, the normal volt-
age dependence of partially uncoupled release chan-
nels provides strong evidence in support for the con-
clusion that the exon 102 mutations result in a funda-
mentally distinct phenotype from that which arises from
mutations that lead to leaky SR Ca2  release channels.
Caffeine and voltage-gated Ca2  release were re-
duced to a similar degree for all but one of the exon
102 mutants (Fig. 5 C). These results could be ex-
plained by exon 102 mutations that inhibit Ca2  ﬂux
through the release channel in a manner that is inde-
pendent of the precise activation mechanism. This
could occur by mutations that alter the gating and/or
Ca2  permeation of the open release channel. The one
exception to this rule was that voltage-gated Ca2  re-
lease through R4892W mutant release channels was re-
duced to a far greater extent than that observed upon
addition of caffeine (Fig. 5). These results demonstrate
that R4892W mutant release channels are in fact able
to conduct Ca2  ions under certain activation para-
digms (e.g., caffeine) but not others (voltage, 4-cmc).
In addition, since the R4892W mutation inhibited volt-
age-gated and 4-cmc–induced Ca2  release similarly, it
is tempting to speculate that 4-cmc may activate RyR1
by a mechanism analogous to that of the voltage sensor.
In any event, these results indicate that while voltage-
gated Ca2  release is reduced for all EC-uncoupled re-
lease channels, EC uncoupling is not necessarily synon-
ymous with a Ca2 -impermeant channel. Thus, in addi-
tion to altering the pore of the release channel, it is
conceivable that EC uncoupling (i.e., reduced voltage-
gated release in the absence of store depletion) could
also arise from CCD mutations in RyR1 (or the DHPR)
that either (a) perturb RyR1 (or DHPR) junctional tar-
geting, (b) result in DHPR/RyR1 expression level mis-
match, (c) alter appropriate assembly of DHPR tetrads
or RyR1 arrays, or (d) disrupt functional coupling be-
tween properly targeted/assembled DHPR and RyR1
proteins (Dirksen and Avila, 2002). Thus, while muta-
tions within exon 102 of the RyR1 gene represent a
hotspot for EC uncoupling, mutations within other
functional domains of the channel could potentially
lead to mechanistically distinct forms of EC uncoupling.
Therapeutic Implications for Two Distinct Mechanisms of 
Muscle Weakness in CCD
Currently, there are no effective therapies for the treat-
ment of muscle weakness or core development in CCD.
However, normalization of muscle Ca2  homeostasis by
interventions expected to block SR Ca2  leak could po-
tentially improve muscle performance in forms of CCD
that result from excessive leak of SR Ca2  through CCD
mutant RyR1 channels. Our results in which resting
Ca2  and SR Ca2  content are restored to normal lev-
els in dyspedic myotubes expressing double mutants
that combine the I4897T “EC uncoupled” mutation
with NH2-terminal or COOH-terminal “leaky” channels
(Fig. 1) provides sound preliminary rationale for such
an idea. However, although levels of resting Ca2  and
SR Ca2  content are normal, EC coupling is completely
“uncoupled” (i.e., no voltage-gated release) in myo-
tubes expressing the double mutants; a result not unex-
pected if the I4897T mutation results in release chan-
nels that only poorly permeate Ca2 . Thus, any effec-
tive therapeutic approach designed to counteract SR
Ca2  loss through leaky SR Ca2  release channels
would need to restore both resting Ca2  and SR con-
tent and also promote normalization of voltage-gated
SR Ca2  release.
Dantrolene, an FDA-approved agent used in the
treatment of MH crises (McCarthy et al., 2000), may
represent an intriguing candidate for counteracting
Ca2  dysregulation resulting from leaky SR Ca2  release
channels. Dantrolene is thought to antagonize MH epi-
sodes by reducing skeletal muscle twitch force and
shifting the sensitivity of contractile activation to more
depolarized voltages (Hainaut and Desmedt, 1974), an
effect diametrically opposed to that caused by CCD mu-
tations in RyR1 that result in leaky SR Ca2  release
channels (where the voltage dependence of Ca2  re-
lease is shifted to more hyperpolarized potentials) (Fig.T
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2; Avila and Dirksen, 2001). However, the precise
mechanism by which dantrolene alters SR Ca2  release
is still unclear since a more recent report has shown
that dantrolene reduces the amplitude of voltage-gated
SR Ca2  release without altering the voltage depen-
dence of Ca2  release in rodent skeletal muscle ﬁbers
(Szentesi et al., 2001). Nevertheless, it will be important
for future experiments to determine whether dan-
trolene can normalize resting Ca2 , SR Ca2  content, as
well as the magnitude and voltage dependence of Ca2 
release attributable to leaky CCD mutant release chan-
nels. In such a case, dantrolene could potentially op-
pose muscle weakness that arises from leaky release
channels (e.g., by inhibiting SR Ca2  loss through leaky
channels) while exacerbating muscle weakness result-
ing from mutations that lead to EC uncoupling (e.g., by
further inhibiting Ca2  release through EC uncoupled
release channels). Such observations would emphasize
the importance of combining information gleaned
from genetic screening of kindreds with the development
and application of speciﬁc therapeutic approaches for
improving muscle strength in CCD.
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